{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:19:43Z","timestamp":1793701183690,"version":"4.5.1"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"\n Importance<\/jats:title>\n Neuroimaging is prevalent in psychiatric research, but there is limited evidence that it improves clinical outcomes. Functional connectivity neuroimaging was recently used to target individualized brain circuits with accelerated transcranial magnetic stimulation (aTMS), with rapid antidepressant effects and US Food and Drug Administration clearance, but the importance of connectivity-based targeting remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate the effect size of connectivity- vs scalp-based targeting of aTMS for treatment-resistant depression.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This randomized clinical trial comparing connectivity- to scalp-based aTMS treatment was conducted between July 2023 and March 2025 with the primary outcome assessed at 1 month posttreatment and follow-up every 3 months for 1 year. Participants, TMS technicians, and study physicians were blinded. The study took place at the Center for Brain Circuit Therapeutics at Mass General Brigham and Harvard Medical School in Boston, Massachusetts. Forty adults aged 22 to 80 years with a primary diagnosis of major depressive disorder with moderate to severe depression per Montgomery-\u00c5sberg Depression Rating Scale (MADRS) score and moderate to severe treatment resistance per Maudsley Staging Method were included. Key exclusion criteria included contraindications to TMS or magnetic resonance imaging, primary psychiatric diagnoses other than major depressive disorder or anxiety disorders, recent rapid-acting antidepressant treatments, and significant neurological or substance use disorders.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n All participants underwent a 41-minute multiecho resting-state functional connectivity scan prior to aTMS, and half of them received treatment guided by these data. The connectivity-based target was defined as the left dorsolateral prefrontal cortex region with the greatest correlation to a published and publicly available convergent depression circuit. This circuit includes multiple brain regions linked to depression, including negative connectivity to the subgenual cingulate cortex. The scalp-based target was identified with the Beam F3 method.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n MADRS score 1 month after treatment, adjusted for baseline.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In total, 40 participants (22 female [55%]; mean [SD] age, 45.7 [15.2] years) were randomized and treated. The median (IQR) MADRS score reduction was 24 (19-28) vs 18 (10-23) points with connectivity- vs scalp-based targeting, respectively (\n P<\/jats:italic>\n \u2009=\u2009.02). Connectivity-based targeting had an effect size of 0.8 (Cohen\n d<\/jats:italic>\n analog) and 95% CI of 0.26-1.54, with a number needed to scan of 5 individuals. Individualized targets were reproducible within an individual (4.47 mm split-half distance) and different between individuals (12.97 mm) (\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, individualized, connectivity-based targeting of the convergent depression circuit enhanced the antidepressant effects of high-dose aTMS. These results could facilitate cost-effectiveness analyses and help to power a confirmatory efficacy trial.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05680727<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2026.1100","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:32:59Z","timestamp":1782315179000},"page":"807","source":"Crossref","is-referenced-by-count":18,"title":["Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression"],"prefix":"10.1001","volume":"83","author":[{"given":"Joseph J.","family":"Taylor","sequence":"first","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina R.","family":"Kare","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Haj-Darwish","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Khosravani","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Leach","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna","family":"Bomer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Chiulli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Steuber","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Drew","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan T.","family":"Palm","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Chandra","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer B.","family":"Frandsen","sequence":"additional","affiliation":[{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Bekou","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Barbour","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena R.","family":"Baratono","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gonsalvez","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Lyndon","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic L. W. V. J.","family":"Schaper","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Medicine, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Silbersweig","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan H.","family":"Siddiqi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Fox","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Brain Circuit Therapeutics, Mass General Brigham, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Mass General Brigham, Boston, Massachusetts"},{"name":"Department of Neurology, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"yoi260026r1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.2019.11456","article-title":"Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016.","volume":"322","author":"Smith-Bindman","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"yoi260026r3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1176\/appi.ajp.2021.20101429","article-title":"Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial.","volume":"179","author":"Cole","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"10","key":"yoi260026r5","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.biopsych.2021.02.015","article-title":"Identification of personalized transcranial magnetic stimulation targets based on subgenual cingulate connectivity: an independent replication.","volume":"90","author":"Siddiqi","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"12","key":"yoi260026r6","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41562-021-01161-1","article-title":"Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease.","volume":"5","author":"Siddiqi","year":"2021","journal-title":"Nat Hum Behav"},{"key":"yoi260026r7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neuroimage.2012.10.082","article-title":"Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity.","volume":"66","author":"Fox","year":"2013","journal-title":"Neuroimage"},{"issue":"1","key":"yoi260026r8","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1038\/s41598-022-21905-x","article-title":"Individualized precision targeting of dorsal attention and default mode networks with rTMS in traumatic brain injury-associated depression.","volume":"13","author":"Siddiqi","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"yoi260026r9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.biopsych.2023.11.013","article-title":"Personalized and circuit-based transcranial magnetic stimulation: evidence, controversies, and opportunities.","volume":"95","author":"Cash","year":"2024","journal-title":"Biol Psychiatry"},{"issue":"7","key":"yoi260026r10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.biopsych.2012.04.028","article-title":"Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.","volume":"72","author":"Fox","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yoi260026r11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopsych.2017.10.028","article-title":"Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites.","volume":"84","author":"Weigand","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yoi260026r12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brs.2008.09.006","article-title":"An efficient and accurate new method for locating the F3 position for prefrontal TMS applications.","volume":"2","author":"Beam","year":"2009","journal-title":"Brain Stimul"},{"issue":"3","key":"yoi260026r13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.brs.2020.01.010","article-title":"Reliability of targeting methods in TMS for depression: beam F3 vs. 5.5 cm.","volume":"13","author":"Trapp","year":"2020","journal-title":"Brain Stimul"},{"issue":"5","key":"yoi260026r14","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.brs.2023.09.006","article-title":"A randomized trial comparing beam F3 and 5.5 cm targeting in rTMS treatment of depression demonstrates similar effectiveness.","volume":"16","author":"Trapp","year":"2023","journal-title":"Brain Stimul"},{"issue":"2","key":"yoi260026r15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4088\/JCP.08m04309","article-title":"A multidimensional tool to quantify treatment resistance in depression: the Maudsley Staging Method.","volume":"70","author":"Fekadu","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"Pt 7","key":"yoi260026r16","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/brain\/awu109","article-title":"Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study.","volume":"137","author":"Li","year":"2014","journal-title":"Brain"},{"key":"yoi260026r17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroimage.2017.08.025","article-title":"Real-time motion analytics during brain MRI improve data quality and reduce costs.","volume":"161","author":"Dosenbach","year":"2017","journal-title":"Neuroimage"},{"key":"yoi260026r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116091","article-title":"Image processing and analysis methods for the Adolescent Brain Cognitive Development study.","volume":"202","author":"Hagler","year":"2019","journal-title":"Neuroimage"},{"issue":"13","key":"yoi260026r19","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1002\/hbm.25330","article-title":"Personalized connectivity-guided DLPFC-TMS for depression: advancing computational feasibility, precision and reproducibility.","volume":"42","author":"Cash","year":"2021","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"yoi260026r20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/appi.ajp.2019.19070720","article-title":"Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression.","volume":"177","author":"Cole","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"26","key":"yoi260026r21","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment.","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med"},{"key":"yoi260026r22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev-psych-122414-033702","article-title":"Experiments with more than one random factor: designs, analytic models, and statistical power.","volume":"68","author":"Judd","year":"2017","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"yoi260026r23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12888-018-1679-x","article-title":"Standardisation framework for the Maudsley staging method for treatment resistance in depression.","volume":"18","author":"Fekadu","year":"2018","journal-title":"BMC Psychiatry"},{"key":"yoi260026r24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/da.22060","article-title":"Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials.","volume":"30","author":"Berlim","year":"2013","journal-title":"Depress Anxiety"},{"issue":"6977","key":"yoi260026r25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect.","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"4","key":"yoi260026r26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/bmjebm-2020-111569","article-title":"Effect size reporting among prominent health journals: a case study of odds ratios.","volume":"26","author":"Chu","year":"2020","journal-title":"BMJ Evid Based Med"},{"issue":"2","key":"yoi260026r27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamainternmed.2020.4799","article-title":"Characteristics and reporting of number needed to treat, number needed to harm, and absolute risk reduction in controlled clinical trials, 2001-2019.","volume":"181","author":"Elliott","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"5","key":"yoi260026r28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/jama.297.5.468-b","article-title":"Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.","volume":"297","author":"Furukawa","year":"2007","journal-title":"JAMA"},{"issue":"2 suppl","key":"yoi260026r29","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition.","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"10","key":"yoi260026r30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jamapsychiatry.2023.2225","article-title":"Prevalence of neuroradiological abnormalities in first-episode psychosis: a systematic review and meta-analysis.","volume":"80","author":"Blackman","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"yoi260026r31","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jama.2021.0377","article-title":"Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US preventive services task force.","volume":"325","author":"Jonas","year":"2021","journal-title":"JAMA"},{"key":"yoi260026r32","doi-asserted-by":"publisher","first-page":"g3701","DOI":"10.1136\/bmj.g3701","article-title":"Modern mammography screening and breast cancer mortality: population study.","volume":"348","author":"Weedon-Fekj\u00e6r","year":"2014","journal-title":"BMJ"},{"key":"yoi260026r33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"6","key":"yoi260026r34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.biopsych.2023.11.011","article-title":"Targeting symptom-specific networks with transcranial magnetic stimulation.","volume":"95","author":"Siddiqi","year":"2024","journal-title":"Biol Psychiatry"},{"issue":"5","key":"yoi260026r35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1176\/appi.ajp.2019.19090915","article-title":"Distinct symptom-specific treatment targets for circuit-based neuromodulation.","volume":"177","author":"Siddiqi","year":"2020","journal-title":"Am J Psychiatry"},{"key":"yoi260026r36","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-026-03535-1","article-title":"Circuit-targeted modulation of anxiety symptoms in individuals with major depression: a randomized head-to-head TMS trial.","author":"Taylor","year":"2026","journal-title":"Mol Psychiatry"},{"issue":"1","key":"yoi260026r37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1037\/0022-006X.54.1.54","article-title":"Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison.","volume":"54","author":"Lambert","year":"1986","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"yoi260026r39","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.brs.2024.07.009","article-title":"Accelerated transcranial magnetic stimulation: a pilot study of safety and efficacy using a pragmatic protocol.","volume":"17","author":"Luehr","year":"2024","journal-title":"Brain Stimul"},{"key":"yoi260026r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115482","article-title":"Real world efficacy and safety of various accelerated deep TMS protocols for major depression.","volume":"328","author":"Roth","year":"2023","journal-title":"Psychiatry Res"},{"issue":"1","key":"yoi260026r41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S146114570900008X","article-title":"Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.","volume":"13","author":"Paill\u00e8re Martinot","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"yoi260026r42","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/npp.2008.233","article-title":"A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression.","volume":"34","author":"Fitzgerald","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"yoi260026r43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317597","article-title":"Repetitive transcranial magnetic stimulation targeted with MRI based neuro-navigation in major depressive episode: a double-blind, multicenter randomized controlled trial.","volume":"20","author":"Millet","year":"2025","journal-title":"PLoS One"},{"issue":"2","key":"yoi260026r44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41591-023-02764-z","article-title":"Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial.","volume":"30","author":"Morriss","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"yoi260026r45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brs.2018.10.004","article-title":"Limits and reproducibility of resting-state functional MRI definition of DLPFC targets for neuromodulation.","volume":"12","author":"Ning","year":"2019","journal-title":"Brain Stimul"},{"issue":"7","key":"yoi260026r46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038430","article-title":"Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND).","volume":"10","author":"Morriss","year":"2020","journal-title":"BMJ Open"},{"key":"yoi260026r47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2018.02.019","article-title":"Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression.","volume":"232","author":"Taylor","year":"2018","journal-title":"J Affect Disord"},{"issue":"6","key":"yoi260026r48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41583-022-00583-8","article-title":"Causal mapping of human brain function.","volume":"23","author":"Siddiqi","year":"2022","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"yoi260026r49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ana.25387","article-title":"Challenges of differential placebo effects in contemporary medicine: the example of brain stimulation.","volume":"85","author":"Burke","year":"2019","journal-title":"Ann Neurol"},{"issue":"8","key":"yoi260026r50","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0895-4356(00)00206-7","article-title":"Do medical devices have enhanced placebo effects?","volume":"53","author":"Kaptchuk","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"yoi260026r51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuron.2008.06.030","article-title":"New insights into the placebo and nocebo responses.","volume":"59","author":"Enck","year":"2008","journal-title":"Neuron"},{"key":"yoi260026r52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fpsyt.2018.00243","article-title":"How placebo needles differ from placebo pills?","volume":"9","author":"Chae","year":"2018","journal-title":"Front Psychiatry"},{"issue":"7","key":"yoi260026r53","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/PSY.0b013e3182294a50","article-title":"The nocebo effect and its relevance for clinical practice.","volume":"73","author":"Colloca","year":"2011","journal-title":"Psychosom Med"},{"issue":"Pt 11","key":"yoi260026r54","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1093\/brain\/awn116","article-title":"Placebo effects: clinical aspects and neurobiology.","volume":"131","author":"Oken","year":"2008","journal-title":"Brain"},{"issue":"7","key":"yoi260026r55","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S1474-4422(16)00066-1","article-title":"Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects.","volume":"15","author":"Benedetti","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"yoi260026r56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41235-023-00463-4","article-title":"Expensive seems better: the price of a non-effective drug modulates its perceived efficacy.","volume":"8","author":"D\u00edaz-Lago","year":"2023","journal-title":"Cogn Res Princ Implic"},{"key":"yoi260026r57","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.84691","article-title":"Presenting a sham treatment as personalised increases the placebo effect in a randomised controlled trial.","volume":"12","author":"Sandra","year":"2023","journal-title":"Elife"},{"key":"yoi260026r2","unstructured":"DHHS. CMS Manual System. July 2024 Update of the Hospital Outpatient Prospective Payment System (OPPS). Published 2024. Accessed January 1, 2026. https:\/\/www.cms.gov\/files\/document\/r12665cp.pdf"},{"key":"yoi260026r4","unstructured":"FDA. Magnus neuromodulation system (MNS) with SAINT Technology, Model Number 1001K. 2022. Accessed June 1, 2026. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K220177&utm"},{"key":"yoi260026r38","doi-asserted-by":"crossref","unstructured":"DeSouza? D, Meng? NF, DeGaetano? NP, . Naturalistic outcomes with fMRI-guided and non-fMRI-guided accelerated TMS for depression.? medRxiv. 2025. doi:10.1101\/2025.09.03.25334813","DOI":"10.1101\/2025.09.03.25334813"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2850583\/jamapsychiatry_taylor_2026_oi_260026_1791302049.87996.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:01:06Z","timestamp":1791385266000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2850583"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.1100","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}